175 related articles for article (PubMed ID: 34662253)
1. Acute myocardial infarction therapy:
Wang J; Zhang S; Di L
Drug Deliv; 2021 Dec; 28(1):2198-2204. PubMed ID: 34662253
[TBL] [Abstract][Full Text] [Related]
2. Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction.
Zhang S; Li J; Hu S; Wu F; Zhang X
Int J Nanomedicine; 2018; 13():4045-4057. PubMed ID: 30022826
[TBL] [Abstract][Full Text] [Related]
3. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
Zhang S; Wang J; Pan J
Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
[TBL] [Abstract][Full Text] [Related]
4. Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system.
Guo J; Xing X; Lv N; Zhao J; Liu Y; Gong H; Du Y; Lu Q; Dong Z
Biomed Pharmacother; 2019 Dec; 120():109480. PubMed ID: 31562980
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation.
Yu J; Li W; Yu D
Drug Des Devel Ther; 2018; 12():1697-1706. PubMed ID: 29928113
[TBL] [Abstract][Full Text] [Related]
6. α
Qiu J; Cai G; Liu X; Ma D
Biomed Pharmacother; 2017 Dec; 96():1418-1426. PubMed ID: 29079344
[TBL] [Abstract][Full Text] [Related]
7. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model.
Dong Z; Guo J; Xing X; Zhang X; Du Y; Lu Q
Biomed Pharmacother; 2017 May; 89():297-304. PubMed ID: 28236703
[TBL] [Abstract][Full Text] [Related]
8. Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis.
Li WQ; Wu JY; Xiang DX; Luo SL; Hu XB; Tang TT; Sun TL; Liu XY
Int J Nanomedicine; 2019; 14():8345-8360. PubMed ID: 31695371
[TBL] [Abstract][Full Text] [Related]
9. Acute myocardial infarction therapy using calycosin and tanshinone co-loaded; mitochondrion-targeted tetrapeptide and cyclic arginyl-glycyl-aspartic acid peptide co-modified lipid-polymer hybrid nano-system: preparation, characterization, and anti myocardial infarction activity assessment.
Yan J; Guo J; Wang Y; Xing X; Zhang X; Zhang G; Dong Z
Drug Deliv; 2022 Dec; 29(1):2815-2823. PubMed ID: 36047255
[TBL] [Abstract][Full Text] [Related]
10. Anti prostate cancer using PEGylated bombesin containing, cabazitaxel loading nano-sized drug delivery system.
Chen W; Guo M; Wang S
Drug Dev Ind Pharm; 2016 Dec; 42(12):1968-1976. PubMed ID: 27143168
[TBL] [Abstract][Full Text] [Related]
11. Hydroxycamptothecin (HCPT)-loaded PEGlated lipid-polymer hybrid nanoparticles for effective delivery of HCPT: QbD-based development and evaluation.
Ma Z; Liu J; Li X; Xu Y; Liu D; He H; Wang Y; Tang X
Drug Deliv Transl Res; 2022 Jan; 12(1):306-324. PubMed ID: 33712991
[TBL] [Abstract][Full Text] [Related]
12. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles.
Liu J; Cheng H; Han L; Qiang Z; Zhang X; Gao W; Zhao K; Song Y
Drug Des Devel Ther; 2018; 12():3199-3209. PubMed ID: 30288024
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
[TBL] [Abstract][Full Text] [Related]
14. An efficient and long-acting local anesthetic: ropivacaine-loaded lipid-polymer hybrid nanoparticles for the control of pain.
Li A; Yang F; Xin J; Bai X
Int J Nanomedicine; 2019; 14():913-920. PubMed ID: 30774342
[TBL] [Abstract][Full Text] [Related]
15. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
16. Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor-Afatinib: In vitro and in vivo evaluation.
Wang J; Su G; Yin X; Luo J; Gu R; Wang S; Feng J; Chen B
Biomed Pharmacother; 2019 Dec; 120():109493. PubMed ID: 31586902
[TBL] [Abstract][Full Text] [Related]
17. Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.
Kasama S; Furuya M; Toyama T; Ichikawa S; Kurabayashi M
Eur Heart J; 2008 Jun; 29(12):1485-94. PubMed ID: 18490430
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of a large-scale trial using atrial natriuretic peptide (ANP) as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic Damage by ANP (J-WIND-ANP).
Asakura M; Jiyoong K; Minamino T; Shintani Y; Asanuma H; Kitakaze M;
Circ J; 2004 Feb; 68(2):95-100. PubMed ID: 14745141
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
[TBL] [Abstract][Full Text] [Related]
20. Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.
Shao M; Yang W; Han G
Int J Nanomedicine; 2017; 12():7121-7130. PubMed ID: 29026305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
